About this trial
This study is a multicenter, prospective cohort study of patients diagnosed with respiratory monogenic diseases, the clinical information of recruited patients, including clinical manifestations, lung function, chest imaging, quality of life and other indicators, will be followed for 5 years.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age: 0-18 years, male and female.
Any organ system symptoms consistent with the diagnostic points of respiratory monogenic diseases.
Agree to retain specimens related to disease research and agree to store the specimens in the sample bank.
willing and able to cooperate with long-term follow-up.
Disqualifiers
It is unable to provide complete medical records or the current condition can not accept the diagnosis process
She or he cannot agree to participate in the study.
Trial population
Children who was confirmed diagnosis as respiratory monogenic diseases at the certain hospitals (sponsor and collaborators)
Trial design
Case-only
Prospective
Treatments tested in this trial
- Other intervention
observation
Treatment groups
Trial outcomes
Primary outcomes
Change from baseline in lung function on the spirometry
forced expiratory volume at one second (FEV1) in Liter
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Kunling Shen
Lead sponsor
Beijing Children's Hospital
Sponsor institution
Capital Institute of Pediatrics, China
Collaborator
Shengjing Hospital
Collaborator
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Collaborator
The Children's Hospital of Zhejiang University School of Medicine
Collaborator
Children's Hospital of Chongqing Medical University
Collaborator
The first clinical college of Guangzhou medical university
Collaborator
Guangzhou Women and Children's Medical Center
Collaborator
Yuying Children's Hospital of Wenzhou Medical University
Collaborator